| __timestamp | Ionis Pharmaceuticals, Inc. | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 241751000 | 176081000 |
| Thursday, January 1, 2015 | 322292000 | 157939000 |
| Friday, January 1, 2016 | 344320000 | 164073000 |
| Sunday, January 1, 2017 | 374644000 | 169243000 |
| Monday, January 1, 2018 | 1820000 | 168489000 |
| Tuesday, January 1, 2019 | 4000000 | 172526000 |
| Wednesday, January 1, 2020 | 12000000 | 200649000 |
| Friday, January 1, 2021 | 11000000 | 237513000 |
| Saturday, January 1, 2022 | 14000000 | 353358000 |
| Sunday, January 1, 2023 | 9133000 | 586886000 |
| Monday, January 1, 2024 | 11215000 |
Unleashing insights
In the competitive landscape of the pharmaceutical industry, understanding cost structures is crucial. Lantheus Holdings, Inc. and Ionis Pharmaceuticals, Inc. offer a fascinating comparison. Over the past decade, Lantheus has seen a steady increase in its cost of revenue, peaking in 2023 with a staggering 233% rise from 2014. This growth reflects their expanding operations and market reach. In contrast, Ionis Pharmaceuticals experienced a dramatic fluctuation, with costs plummeting by 96% from 2017 to 2018, before stabilizing in recent years. This volatility could indicate strategic shifts or operational challenges. By 2023, Lantheus's cost of revenue was over 6 times that of Ionis, highlighting differing business models and market strategies. Such insights are invaluable for investors and industry analysts seeking to understand the financial health and strategic direction of these companies.
Cost Insights: Breaking Down Sanofi and Ionis Pharmaceuticals, Inc.'s Expenses
Cost of Revenue Trends: Bristol-Myers Squibb Company vs Ionis Pharmaceuticals, Inc.
Cost of Revenue Trends: Incyte Corporation vs Lantheus Holdings, Inc.
Comparing Cost of Revenue Efficiency: Intra-Cellular Therapies, Inc. vs Ionis Pharmaceuticals, Inc.
Analyzing Cost of Revenue: BioMarin Pharmaceutical Inc. and Lantheus Holdings, Inc.
Analyzing Cost of Revenue: BioMarin Pharmaceutical Inc. and Ionis Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Jazz Pharmaceuticals plc vs Ionis Pharmaceuticals, Inc.
Lantheus Holdings, Inc. vs Perrigo Company plc: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Lantheus Holdings, Inc. and Supernus Pharmaceuticals, Inc.'s Expenses
Lantheus Holdings, Inc. vs Evotec SE: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Ionis Pharmaceuticals, Inc. and Travere Therapeutics, Inc.
Cost of Revenue: Key Insights for Ionis Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.